Yalamanchili, T., Mohta, S. and Tran, D. 2022. Administration of Mesenchymal Stem Cells as a Therapeutic for Amyotrophic Lateral Sclerosis. Berkeley Pharma Tech Journal of Medicine. 2, 2 (Dec. 2022), 70–103.